Orbifloxacin (brand name Orbax) is a fluoroquinolone antibiotic which is approved for use in dogs,[1][2] marketed by Schering-Plough Animal Health.
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATCvet code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.166.510 |
Chemical and physical data | |
Formula | C19H20F3N3O3 |
Molar mass | 395.382 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
See also
editReferences
edit- ^ "Product Abstract - NADA 141-081". American College of Veterinary Clinical Pharmacology. Retrieved 21 June 2008.[dead link ]
- ^ Papich MG (October 2020). "Orbifloxacin". Papich Handbook of Veterinary Drugs (Fifth ed.). St. Louis, Missouri: Elsevier Health Sciences. p. 674. ISBN 978-0-323-70958-3.